Denarius Metals Announces Upsize of LIFE Offering and Launches Concurrent Private Placement
aTyr PharmaaTyr Pharma(US:LIFE) Newsfile·2025-11-13 23:15

Core Viewpoint - Denarius Metals Corp. has announced an increase in the size of its non-brokered private placement offering due to strong investor demand, raising the total offering to up to CA$10,000,000 [1][4] Offering Details - The LIFE Offering has been increased to up to 20,000,000 Units for gross proceeds of up to CA$10,000,000, while a Concurrent Offering of up to 5,500,000 Units at CA$0.50 per Unit aims for gross proceeds of up to CA$2,750,000 [1][2] - The total potential issuance from both offerings is 25,500,000 Units for gross proceeds of up to CA$12,750,000 [1] Unit Composition - Each Unit will consist of one common share and one-half of one common share purchase warrant, with each whole Warrant allowing the purchase of one common share at CA$0.70, exercisable 60 days after the closing date [2] Regulatory Compliance - The Units will be offered to purchasers in Canada (excluding Québec) under the Listed Issuer Financing Exemption and other exemptions under National Instrument 45-106 [3] - The maximum amount under the Listed Issuer Exemption for the LIFE Offering is CA$10,000,000 [3] Use of Proceeds - The net proceeds from the Offerings will be allocated to fund exploration and development at the Zancudo Project in Colombia, as well as for working capital and general corporate purposes [4] Company Overview - Denarius Metals is a Canadian junior company focused on the acquisition, exploration, development, and operation of precious metals and polymetallic mining projects in Colombia and Spain [10] - The company operates the Zancudo Project, a high-grade gold-silver deposit, and has interests in several projects in Spain, including the Aguablanca Project, recognized as a Strategic Project by the EU [11][12]